It was not possible for a vaccine maker, or a society, to adapt to an evolving virus without genomic information. And yet nearly a year into the pandemic, in February 2021, the number of genomes being sequenced in the United States was trivial—less than a third of 1 percent of the virus in people who tested positive.
